Improving the Detection of Drivers Impaired by Cannabis: Supplementing the Standardized Field Sobriety Test
Outlines evidence suggesting the Standardized Field Sobriety Test can be supplemented with other tests and observations to help law enforcement officers detect potential cannabis impairment in driv
Substance Use and the Climate Emergency
Explores how people who use drugs and the climate emergency interconnect. For example, in 2021 flooding in British Columbia disrupted people’s access to opioid agonist treatment.
Comparing Drug Treatment Court Principles to Evidence-Based Practice
Explains the Canadian drug treatment court (DTC) model and explores the extent to which it adheres to international standards of care for the design and delivery of evidence-based interventions for
Drug Treatment Courts: An Evidence-Based Review with Recommendations for Improvement
Defines what drug treatment courts (DTCs) are, situates them in Canada’s current substance use environment and reviews issues related to outcomes.
Meeting Critical Needs: Evidence with Impact – CCSA Annual Report, 2022–2023
Outlines CCSA’s activities in fiscal year 2022–2023 and provides the auditor’s report.
Closing the Gaps: Cannabis Research Summary Report
Summarizes key findings of the Closing the Gaps studies, specifically the legalization impact, medical use versus nonmedical use, mental and physical health effects, purchase decisions, modalities
Pediatric Cannabis Poisoning Stakeholder Toolkit
Presents key facts, social media graphics and messaging to help organizations raise awareness of pediatric cannabis poisoning through public education campaigns.
CCENDU Bulletin: Update on Xylazine in Canada and the United States
This Bulletin updates recent data on xylazine’s presence in the unregulated drug supply from a CCENDU alert in July 2022.
